NPPB and metabolic syndrome: In model 3, individuals in the BNP Q1 and Q2 quartiles had increased risks for nonfasting dyslipidemia (OR [95 % CI] for BNP Q1: TC 2.042 [1.192–3.500], P = 0.009; Q2: TC 2.316 [1.372–3.911], P = 0.002; BNP Q1: TAG 3.938 [2.013–7.702], P < 0.0001; Q2: TAG 2.134 [1.051–4.336], P = 0.036).